UP!

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q4 2020 2021-03-08 Future report Set alerts
Q3 2020 2020-11-02 Future report Set alerts
Q2 2020 2020-08-10 0.29 0.29
Q1 2020 2020-05-11 -0.35 -0.35
Q4 2019 2020-03-10 -0.26 -0.26
Q3 2019 2019-11-04 -0.22 -0.22
Q2 2019 2019-08-05 -0.26 -0.26
Q1 2019 2019-05-06 -0.23 -0.23
Q4 2018 2019-03-11 -0.21 -0.21
Q3 2018 2018-11-08 -0.22 -0.22

Ratings

2016-05-19 Reiterated Rating Cowen and Company Hold
2016-03-14 Reiterated Rating Cowen and Company Hold
2016-01-07 Reiterated Rating Cowen and Company Market Perform
2015-09-24 Reiterated Rating JPMorgan Chase & Co. Buy
2015-05-18 Upgrade JPMorgan Chase & Co. Neutral to Overweight $7.00 to $14.00
2014-11-06 Downgrade Cowen and Company Outperform to Market Perform
2014-01-13 Initiated Coverage Goldman Sachs Neutral $7.00
2013-12-04 Downgrade Citigroup Inc. Buy to Neutral
2012-11-14 Initiated Stifel Nicolaus Buy $16
2016-05-19 Reiterated Rating Cowen and Company Hold
2016-03-14 Reiterated Rating Cowen and Company Hold
2016-01-07 Reiterated Rating Cowen and Company Market Perform
2015-09-24 Reiterated Rating JPMorgan Chase & Co. Buy
2015-05-18 Upgrade JPMorgan Chase & Co. Neutral to Overweight $7.00 to $14.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
Schall Thomas J. President and CEO 5.04%  (2184994) CCXI /
Edwards Thomas A. 0.32%  (138785) CCXI /
LUCAS ROGER C 0.22%  (93846) CCXI / TECH /
FECZKO JOSEPH M 0.19%  (82096) CCXI / KERX /
Bekker Petrus SVP of Medical & Clinical 0.14%  (59839) CCXI /
Tyree James L 0.12%  (53849) CCXI / DEPO / THRX /
Parker Geoffrey M. 0.11%  (45671) ANAC / CCXI / GHDX / PRGO / SNSS /
MCKINNELL HENRY A 0.10%  (44218) CCXI / MCO /
KANAYA SUSAN M SVP, Finance, CFO and Sec. 0.09%  (38135) CCXI /
Jaen Juan C. SVP, Drug Discovery & CSO 0.07%  (30000) CCXI /
Cappel Markus J. Chief Bus. Officer & Treasurer 0.05%  (23826) CCXI /
KLEIN IRA 0.04%  (16216) CCXI /
SINGH RAJINDER SVP, Research 0.02%  (10000) CCXI /

Comments